The vaccine pipeline, beyond Pfizer and Moderna

America has become a two-vaccine nation, but plenty of other companies are continuing to work on new vaccines that could increase supply and accelerate the country's goal of herd immunity. Dan digs into the vaccine pipeline with Derek Lowe, a medicinal chemist and biotech blogger.

Om Podcasten

Each weekday afternoon, Axios unpacks the biggest story of the day and why it matters. We'll take you inside the accelerating forces, technologies and trends that are remaking your world and work. About Axios: Axios is a digital media company launched in 2017. Axios - which means “worthy” in Greek - helps you become smarter, faster with news and information across politics, tech, business, media, science and the world. Subscribe to our newsletters at axios.com/newsletters and download our mobile app at axios.com/app.  Axios Re:Cap is on hiatus until October 2021.